PureTech Health Quote - PRTC

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

17.33

Bid

17.21

Ask

17.83

Volume

4,503

17.00 Day's Range 17.51

0.00 52 Week Range 0.00

Market Cap

414.917M

Previous Close

17.60

Open

17.51

Last Trade

17.3

Last Trade Time

11:07:01

Financial Volume

US$ 77,929

VWAP

17.3061

Average Volume (3m)

Shares Outstanding

23,942,131

Dividend Yield

PE Ratio

-0.51

Earnings Per Share (EPS)

-2.74

Revenue

65.12M

Net Profit

-65.7M

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines ... PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, neurological & neuropsychological disorders, among others. It operates in following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept, focused on addressing some of society's healthcare needs. Show more

Sector

Home Health Care Services

Industry

Home Health Care Services

Website

www.puretechhealth.com

Headquarters

London, Gbr

Founded

PureTech Health PLC is listed in the Home Health Care Services sector of the NASDAQ with ticker PRTC. The last closing price for PureTech Health was US$17.60. Over the last year, PureTech Health shares have traded in a share price range of US$ 0.00 to US$ 0.00.

PureTech Health currently has 23,942,131 shares outstanding. The market capitalization of PureTech Health is US$421.38 million. PureTech Health has a price to earnings ratio (PE ratio) of -0.51.

PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)

Single agent and combination data from Phase 1b AML/MDS trial presented at ASH 2024 showed potential of LYT-200 to serve broad range of patients across various lines of treatment LYT-200 is...

PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today...

PureTech Appoints UBS as UK Corporate Broker

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), is pleased to announce that it has appointed UBS as its UK Corporate Broker. About PureTech Health PureTech is a...

PureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial

Dose-ranging trial evaluated deupirfenidone 550 mg three times a day (TID) (approximately equivalent exposure to pirfenidone 801 mg TID1) and deupirfenidone 825 mg TID and successfully...

PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024

Multiple well-tolerated doses with pharmacodynamic activity were identified and will be included in a planned Phase 2b study in major depressive disorder PureTech Health plc (Nasdaq: PRTC, LSE:...

PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting

LYT-200 is generally safe and well-tolerated as a single agent as well as in combination with standard-of-care venetoclax and hypomethylating agents LYT-200 demonstrates clinical benefit as a...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

PRTC - Frequently Asked Questions (FAQ)

What is the current PureTech Health share price?

The current share price of PureTech Health is US$ 17.33

How many PureTech Health shares are in issue?

PureTech Health has 23,942,131 shares in issue

What is the market cap of PureTech Health?

The market capitalisation of PureTech Health is USD 421.38M

What is the 1 year trading range for PureTech Health share price?

PureTech Health has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of PureTech Health?

The price to earnings ratio of PureTech Health is -0.51

What is the cash to sales ratio of PureTech Health?

The cash to sales ratio of PureTech Health is 0.51

What is the reporting currency for PureTech Health?

PureTech Health reports financial results in USD

What is the latest annual turnover for PureTech Health?

The latest annual turnover of PureTech Health is USD 65.12M

What is the latest annual profit for PureTech Health?

The latest annual profit of PureTech Health is USD -65.7M

What is the registered address of PureTech Health?

The registered address for PureTech Health is C/O TMF GROUP, 13TH FLOOR, ONE ANGEL COURT, LONDON, EC2R 7HJ

What is the PureTech Health website address?

The website address for PureTech Health is www.puretechhealth.com

Which industry sector does PureTech Health operate in?

PureTech Health operates in the HOME HEALTH CARE SERVICES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PHIOPhio Pharmaceuticals Corporation	US$ 7.12 (321.30%)	215.05M
SLRXSalarius Pharmaceuticals Inc	US$ 4.20 (168.37%)	102.54M
XXII22nd Century Group Inc	US$ 9.31 (90.39%)	14.41M
ATPCAgape ATP Corporation	US$ 2.3201 (84.13%)	68.06M
VRMEVerifyMe Inc	US$ 4.6737 (83.28%)	28.41M
EHGOEshallgo Inc	US$ 1.30 (-60.24%)	2.41M
CMTLComtech Telecommunications Corporation	US$ 1.9901 (-51.81%)	2.92M
NAYANAYA Biosciences Inc	US$ 0.4901 (-39.75%)	727.67k
SVMHSRIVARU Holding Ltd	US$ 0.03805 (-38.43%)	126.73M
TCTMTCTM Kids IT Education Inc	US$ 0.4541 (-38.18%)	750.09k
GCTKGlucoTrack Inc	US$ 0.144001 (23.08%)	596.35M
PHIOPhio Pharmaceuticals Corporation	US$ 7.14 (322.49%)	215.05M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.06325 (-28.21%)	141.5M
SVMHSRIVARU Holding Ltd	US$ 0.03805 (-38.43%)	126.73M
NVDANVIDIA Corporation	US$ 131.9205 (-2.94%)	121.6M